JPWO2025159067A1 - - Google Patents

Info

Publication number
JPWO2025159067A1
JPWO2025159067A1 JP2025546071A JP2025546071A JPWO2025159067A1 JP WO2025159067 A1 JPWO2025159067 A1 JP WO2025159067A1 JP 2025546071 A JP2025546071 A JP 2025546071A JP 2025546071 A JP2025546071 A JP 2025546071A JP WO2025159067 A1 JPWO2025159067 A1 JP WO2025159067A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025546071A
Other languages
Japanese (ja)
Other versions
JP7816735B2 (ja
JPWO2025159067A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2025159067A1 publication Critical patent/JPWO2025159067A1/ja
Publication of JPWO2025159067A5 publication Critical patent/JPWO2025159067A5/ja
Application granted granted Critical
Publication of JP7816735B2 publication Critical patent/JP7816735B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/761—Adenovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2025546071A 2024-01-22 2025-01-21 腫瘍溶解性ウイルス及びそれを用いたがん治療 Active JP7816735B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2024007682 2024-01-22
JP2024007682 2024-01-22
PCT/JP2025/001686 WO2025159067A1 (ja) 2024-01-22 2025-01-21 腫瘍溶解性ウイルス及びそれを用いたがん治療

Publications (3)

Publication Number Publication Date
JPWO2025159067A1 true JPWO2025159067A1 (https=) 2025-07-31
JPWO2025159067A5 JPWO2025159067A5 (https=) 2025-12-23
JP7816735B2 JP7816735B2 (ja) 2026-02-18

Family

ID=96545359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025546071A Active JP7816735B2 (ja) 2024-01-22 2025-01-21 腫瘍溶解性ウイルス及びそれを用いたがん治療

Country Status (3)

Country Link
JP (1) JP7816735B2 (https=)
TW (1) TW202546223A (https=)
WO (1) WO2025159067A1 (https=)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019014696A (ja) * 2017-07-10 2019-01-31 株式会社Ｉｄファーマ 癌の治療組成物
WO2019093435A1 (ja) * 2017-11-08 2019-05-16 国立大学法人 鹿児島大学 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レベルを与える発現制御システムを有する腫瘍溶解性ウイルス（腫瘍溶解性免疫治療）
WO2021029385A1 (ja) * 2019-08-09 2021-02-18 Ｋｍバイオロジクス株式会社 腫瘍溶解性ワクシニアウイルス
JP2021508477A (ja) * 2017-12-29 2021-03-11 オンコラス， インコーポレイテッド 治療用ポリペプチドの腫瘍溶解性ウイルス送達
JP2022536929A (ja) * 2019-06-14 2022-08-22 ティルト バイオセラピューティクス オサケユキチュア 腫瘍溶解性アデノウイルスとチェックポイント阻害剤の併用療法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019014696A (ja) * 2017-07-10 2019-01-31 株式会社Ｉｄファーマ 癌の治療組成物
WO2019093435A1 (ja) * 2017-11-08 2019-05-16 国立大学法人 鹿児島大学 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レベルを与える発現制御システムを有する腫瘍溶解性ウイルス（腫瘍溶解性免疫治療）
JP2021508477A (ja) * 2017-12-29 2021-03-11 オンコラス， インコーポレイテッド 治療用ポリペプチドの腫瘍溶解性ウイルス送達
JP2022536929A (ja) * 2019-06-14 2022-08-22 ティルト バイオセラピューティクス オサケユキチュア 腫瘍溶解性アデノウイルスとチェックポイント阻害剤の併用療法
WO2021029385A1 (ja) * 2019-08-09 2021-02-18 Ｋｍバイオロジクス株式会社 腫瘍溶解性ワクシニアウイルス

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAMDAN, F. ET AL.: "GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses", MOLECULAR THERAPY: METHODS & CLINICAL DEVELOPMENT, vol. 20, JPN6025010574, 2021, pages 625 - 634, ISSN: 0005704505 *
WATANABE, M. ET AL.: "Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy", VIRUSES, vol. 13, no. 2502, JPN6025010576, 2021, ISSN: 0005704506 *

Also Published As

Publication number Publication date
TW202546223A (zh) 2025-12-01
WO2025159067A1 (ja) 2025-07-31
JP7816735B2 (ja) 2026-02-18

Similar Documents

Publication Publication Date Title
CN309946680S (zh) 刀架（zw2510）
CN309947110S (zh) 化妆品塑料瓶（1）
CN309946918S (zh) 线绳调节扣
CN309941338S (zh) 智能杯托
JPWO2025159067A1 (https=)
CA3262105A1 (https=)
CN308403218S (https=)
CN308680352S (https=)
CN308481031S (https=)
CN308404478S (https=)
CN309710251S (https=)
CN308404403S (https=)
CN308404341S (https=)
CN309689030S (https=)
CN308404312S (https=)
CN309683222S (https=)
CN309658279S (https=)
CN308404310S (https=)
CN308403329S (https=)
CN309645772S (https=)
CN309641642S (https=)
CN309641456S (https=)
CN309604856S (https=)
CN309467232S (https=)
CN308417957S (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250806

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250806

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20250806

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20250901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20250901

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251007

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251120

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260127

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260128

R150 Certificate of patent or registration of utility model

Ref document number: 7816735

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150